Summary & Overview

CPT 0581F: Unspecified Clinical Reporting Measure

CPT code 0581F is a CPT-designated reporting code with no summary available in the provided source. Nationally, reporting and tracking codes under CPT are used to capture specific clinical activities, quality metrics, or procedural elements that inform billing, performance measurement, and administrative reporting. Clear identification of such codes matters for consistent claims submission and for aligning clinical documentation with payer requirements.

This publication references standard national payers: Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of what the code represents given the available description, guidance on where data are not available, and a framework for how this code would typically be contextualized in benchmarking and policy discussions once full code details are obtained. The document outlines what to expect in a complete code brief: clinical context and service lines, common sites of service, applicable modifiers and associated taxonomies (if provided), and typical diagnosis linkages for billing.

Where specific details are missing in the input, the summary explicitly notes the absence and indicates that supplemental clinical or billing documentation is required for full interpretation. The focus is national in scope and emphasizes clarity for clinicians, coding staff, and policy analysts who need to map CPT code 0581F to operational workflows and payer submission requirements.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicare0581FCPTreporting-codeclinical-measuremedical-billingservice-lineclaims-submissioncode-reference

Billing Code Overview

CPT code 0581F has no published summary in the source description. Based on the code label provided, this entry represents a specific clinical or procedural reporting measure under the CPT framework.

Service Type: Data not available in the input.
Typical Site of Service: Data not available in the input.

CPT code 0581F is presented here for reference and further specification when additional clinical or billing details become available.

Clinical & Coding Specifications

Clinical Context

A typical patient is a 65-year-old adult undergoing routine evaluation of anticoagulation management following a recent hospitalization for atrial fibrillation or venous thromboembolism. The patient presents to an outpatient anticoagulation clinic or primary care office for a scheduled follow-up to document anticoagulant therapy status, therapeutic goals, and counseling. Clinical workflow includes verification of current anticoagulant medication, assessment of bleeding and thrombotic risk, review of laboratory values (for warfarin: INR), documentation of any dosage adjustments, and communication of plan to the patient and other treating clinicians. The encounter often occurs in an ambulatory clinic or hospital-based outpatient setting and may involve pharmacy-led anticoagulation services, nurse practitioners, or physician oversight. Patient education, medication reconciliation, and scheduling of subsequent monitoring are part of the visit. The service is generally brief and focused on medication management and therapeutic monitoring rather than a comprehensive new problem evaluation.

Coding Specifications

Modifier	Description	When to Use
`25`	Significant, Separately Identifiable Evaluation and Management Service by the Same Physician on the Day of a Procedure	Use when a distinct E/M visit is performed the same day as a minor procedure and it meets documentation requirements.
`26`	Professional Component	Use when billing only the professional component of a service that has a technical component billed by another entity.
`59`	Distinct Procedural Service	Use to indicate a separate, distinct procedure or service on the same day not ordinarily reported together.
`24`	Unrelated E/M Service by the Same Physician During a Postoperative Period	Use for an unrelated E/M visit during a global postoperative period.
`57`	Decision for Surgery	Use when an E/M visit leads to the initial decision to perform surgery (usually preoperative).
`90`	Reference (Outside) Laboratory	Use when reporting services that relied on an outside lab and you are billing professional component only or indicating use of external lab.
`91`	Repeat Clinical Diagnostic Laboratory Test	Use when a lab test is repeated on the same day for confirmation.
`GA`	Waiver of Liability Statement on File (Individual)	Use when ABN or similar advance waiver is on file and required by payer policy.
`QW`	CLIA Waived Test	Use when reporting a CLIA-waived point-of-care test associated with the visit.
`XE`	Separate Encounter, A Service That Is Distinct Because It Occurred During a Separate Encounter	Use to indicate a service provided during a separate encounter from other services billed the same date.

Taxonomy Code	Specialty	Notes
`207Q00000X`	Internal Medicine	Common clinicians providing anticoagulation management and medication monitoring.
`207R00000X`	Family Medicine	Primary care management of chronic anticoagulation and follow-up.
`207L00000X`	Cardiovascular Disease (Cardiology)	Manages anticoagulation in patients with atrial fibrillation and thromboembolic disease.
`352600000X`	Clinical Pharmacist	Pharmacist-led anticoagulation clinics perform dosing adjustments and education under collaborative practice.
`363A00000X`	Nurse Practitioner	Advanced practice providers commonly manage outpatient anticoagulation follow-up.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`I48.91`	Unspecified atrial fibrillation	Common indication for chronic anticoagulation to reduce stroke risk; frequently appears on anticoagulation visit problem lists.
`I82.40`	Acute embolism and thrombosis of unspecified deep veins of lower extremity	Venous thromboembolism is an indication for initiation and monitoring of anticoagulant therapy.
`I26.99`	Other acute pulmonary embolism without acute cor pulmonale	Pulmonary embolism requires inpatient treatment and outpatient anticoagulation follow-up for duration management.
`Z79.01`	Long term (current) use of anticoagulants	Administrative code indicating chronic anticoagulant therapy for monitoring and management.
`D68.52`	Chronic postthrombotic syndrome	Represents long-term sequelae of venous thrombosis that may necessitate ongoing anticoagulation review.
`I63.9`	Cerebral infarction, unspecified	Ischemic stroke patients frequently require anticoagulation assessment when atrial fibrillation or embolic source is present.
`R79.89`	Other specified abnormal findings of blood chemistry	May be used when lab abnormalities (e.g., abnormal coagulation studies) are identified and require follow-up.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`99211`	Office or other outpatient visit for the evaluation and management of an established patient that may not require the presence of a physician	Used for brief anticoagulation follow-up visits with minimal evaluation and low complexity.
`99213`	Office or other outpatient visit for the evaluation and management of an established patient, typically 15 minutes	Common level for routine anticoagulation management requiring medication adjustment and counseling.
`93792`	Anticoagulant management for a patient, including patient assessment, and adjustment of medication dosage, and review of monitoring parameters (per day)	Directly used for structured anticoagulation management services and often billed for pharmacist or clinic-managed dosing.
`85610`	Prothrombin time; plasma or whole blood	Laboratory test (PT/INR) commonly performed to monitor warfarin therapy associated with anticoagulation visits.
`99406`	Smoking and tobacco use cessation counseling intermediate, greater than 3 minutes up to 10 minutes	Often provided adjunctively when counseling patients with vascular risk factors during follow-up visits.